Pharma Drug Regulatory Affairs Certificate Course - DRA 2025
DRA, Orange book, USFDA, eCTD, CTD, INDA, NDA, ANDA, DMF, ICH, Software Demo, RA Jobs, Quiz, Pharma Skills, Updated 2024
4.08 (801 reviews)

7 794
students
7.5 hours
content
Jan 2025
last update
$64.99
regular price
What you will learn
Basic concepts Pharma Regulatory Affairs
Advanced Regulatory Affairs
How Regulatory Authorities Regulates Drug product
Career in Regulatory Affairs
Job opportunities
eCTD & CTD Structure
eCTD Modules
Dossier Preparation & Submission
Drug master file
Submission of Drug Master File
General Demonstration of eCTD Software
General demonstration of eValidator
Registration Process
ICH Guidelines
USFDA regulations: INDA
INDA concept
New drug development
FDA meetings
IND Review process
Market Approvals
Online ESG (Electronic Submission Gateway) tool
Course Gallery




Charts
Students
Price
Rating & Reviews
Coupons Issued
Enrollment Distribution
Comidoc Review
Our Verdict
The Pharma Drug Regulatory Affairs Certificate Course - DRA 2025 offers extensive coverage of essential regulatory concepts and processes. However, improvements in presentation style and value-added explanations beyond mere slide readings would enhance learners' overall experience. The course may benefit from enhanced language proficiency or the addition of closed captions to ensure learners grasp complex topics seamlessly. Nevertheless, learners seeking resources on Pharma Regulatory Affairs could consider this course for its wealth of information and practical demos.
What We Liked
- This course provides a comprehensive overview of various concepts critical to a career in Pharma Regulatory Affairs (DRA), including eCTD & CTD structure, dossier preparation, USFDA regulations, and ICH guidelines.
- The course features valuable resources such as links, appendices, form-filling formats, and software demos that add context to the learning experience. Some learners found these resources helpful for their work.
- A few reviewers appreciated the course's coverage of new terminologies and regulatory processes, enhancing their understanding and knowledge of Pharma Regulatory Affairs.
- Section quizzes and a general eValidator demo have been praised for facilitating practical engagement in an otherwise text-heavy course.
Potential Drawbacks
- Multiple reviewers expressed concerns about the monotonous presentation style, with slides being read word by word without adding value or engaging explanations.
- The course could benefit from improved pronunciation and grammar to ensure clarity in the explanation of complex topics. Some learners struggled to comprehend certain sections due to language proficiency issues.
- Some reviewers mentioned that too much information presented as text made the course less interesting, and that more examples would help illustrate core concepts better.
- A few learners expressed disappointment with the instructor's failure to elaborate on important points or provide additional insights, suggesting that the content could be condensed to focus on critical topics.
Related Topics
3576633
udemy ID
18/10/2020
course created date
07/09/2021
course indexed date
Bot
course submited by